8-K: Milestone Scientific Retains Former CEO as Consultant in Strategic Move

Milestone Scientific has entered into a consulting agreement with its former CEO, Arjan Haverhals, effective January 1, 2025, to leverage his expertise in sales, business strategy, and international expansion.

Summary

• Milestone Scientific has engaged its former CEO, Arjan Haverhals, as a consultant through his company, RH Consulting LLC.
• The consulting agreement commences on January 1, 2025, and continues indefinitely, with termination clauses for disability or by either party with advance notice.
• Mr. Haverhals will provide guidance on sales, business strategies, reimbursement, international expansion, marketing, and R&D.
• He will be paid an annual fee of $350,000, with specific payment schedules for the first and subsequent quarters of 2025.
• The company will also reimburse Mr. Haverhals for reasonable expenses.
• Mr. Haverhals will operate as an independent contractor and will not receive employee benefits.
• He has also signed a non-disclosure, non-solicitation, non-competition, and invention agreement.
• His existing employment agreement with the company expires on December 31, 2024, and his rights under that agreement will be retained until that date.

Sentiment

Score: 7

Explanation: The document indicates a strategic move to retain expertise, which is generally positive. However, the additional expense and reliance on a consultant are potential concerns.

Positives

• The company retains the expertise of its former CEO, ensuring continuity and leveraging his knowledge.
• The consulting agreement covers key areas such as sales, business strategy, and international expansion.
• The agreement provides flexibility with no minimum time requirements for Mr. Haverhals' services.
• The company has the option to terminate the agreement with 30 days notice in the event of disability.
• The company has the option to terminate the agreement with 90 days notice for any reason.

Negatives

• The company will incur an additional expense of $350,000 per year for consulting services.
• The agreement is for an indefinite period, which could lead to long-term financial commitments.
• The company is relying on a consultant who is no longer an employee, which may impact his level of commitment.

Risks

• The effectiveness of the consulting agreement depends on Mr. Haverhals' availability and performance.
• There is a risk that the consulting services may not meet the company's expectations.
• The indefinite nature of the agreement could lead to unforeseen financial obligations.
• The company may face challenges if Mr. Haverhals' consulting services are not aligned with the company's strategic goals.

Future Outlook

The company expects to benefit from Mr. Haverhals' expertise in sales, business strategy, and international expansion through the consulting agreement, starting January 1, 2025.

Management Comments

• Mr. Arjan Haverhals, the Chief Executive Officer of the Company, would continue as a director and, beginning in January 1, 2025, would become a consultant to the Company.

Industry Context

This move is not uncommon in the medical device industry, where companies often retain former executives as consultants to leverage their experience and networks. This is particularly useful for companies undergoing strategic shifts or international expansion.

Comparison to Industry Standards

• Many companies in the medical device sector engage consultants, often former executives, to provide specialized expertise.
• Consulting fees vary widely based on the consultant's experience and the scope of work, but $350,000 per year is within the range for a former CEO.
• Companies like Medtronic and Stryker often use consultants for specific projects or strategic initiatives, similar to Milestone's approach.

Management Changes

Stakeholder Impact

• Shareholders may view this as a positive move to leverage the former CEO's expertise.
• Employees may see this as a sign of stability and continuity.
• Customers and suppliers may not be directly impacted by this agreement.

Next Steps

• The consulting agreement will commence on January 1, 2025.
• Mr. Haverhals will begin providing services as outlined in the agreement.
• The company will monitor the effectiveness of the consulting services.

Key Dates

Keywords

consulting agreement, Arjan Haverhals, Milestone Scientific, CEO, business strategy, sales, international expansion, medical devices, dental, reimbursement, R&D